clinical trials

August 10, 2022
Christopher Flowers, MD, MS, FASCO; Vicki Keedy, MD; Daniel Mulrooney, MD, MS; and Sumanta (Monty) Pal, MD, FASCO

What to Know About Peer-Reviewed Cancer Information and Its Role in Cancer Research

English
Christopher.Flowers.Vicki.Keedy.Daniel.Mulrooney.Sumanta.Pal

In this post, several experts describe the importance of peer-reviewed cancer information, including what “peer reviewed” means, what to know about levels of scientific evidence in cancer research, and the differences between research done in cell lines, animals, and humans.

Read More >>
2022 ASCO Annual Meeting; #ASCO22
May 26, 2022
Greg Guthrie, ASCO Staff

Reunión anual de la ASCO de 2022: Gasto en servicios sociales y supervivencia al cáncer, Concientización sobre ensayos clínicos en personas de raza negra con cáncer de mama, Equidad y telemedicina, y La supervivencia en el neuroblastoma

Spanish
Greg Guthrie

La Reunión Anual de la American Society of Clinical Oncology (Sociedad Estadounidense de Oncología Clínica) de 2022 se llevará a cabo del 3 al 7 de junio. En esta publicación inicial de la investigación que se presenta en la reunión, los estudios examinan cómo la raza, el origen étnico, la pobreza y otros factores sociales y demográficos afectan la vida de las personas con cáncer.

Read More >>
2022 ASCO Annual Meeting; #ASCO22
May 26, 2022
Greg Guthrie, ASCO Staff

2022 ASCO Annual Meeting: Social Services Spending and Cancer Survival, Clinical Trials Awareness Among Black People With Breast Cancer, Telemedicine Use During the Pandemic Is Not Equal, and Factors Affecting Survival in Neuroblastoma

English
Greg Guthrie

The 2022 ASCO Annual Meeting is being held June 3 to 7. In this early release of research being presented at the meeting, studies examine how race, ethnicity, poverty, and other social and demographic factors affect the lives of people with cancer.

Read More >>
2021 ASCO Annual Meeting; #ASCO21
June 3, 2021
ASCO Staff

2021 ASCO Annual Meeting: New Treatments and Research Advances in Esophageal Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, Kidney Cancer, and Nasopharyngeal Cancer

English
ASCO.Staff

The ASCO Annual Meeting begins on June 4, and here is some of the notable research that will be presented. Topics include combined immunotherapy for esophageal cancer, targeted radiation for mCRPC, olaparib for HER2-negative breast cancer, adjuvant chemotherapy for cervical cancer, pembrolizumab for kidney cancer, and toripalimab for nasopharyngeal cancer.

Read More >>

Pages

Subscribe to RSS - clinical trials